Effect of Turmeric on Diabetic Nephropathy
Not Applicable
Completed
- Conditions
- ProteinuriaDiabetic Nephropathy
- Interventions
- Drug: Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker
- Registration Number
- NCT01015937
- Lead Sponsor
- Shaheed Faghihi Hospital
- Brief Summary
The purpose of this study is to investigate whether turmeric is effective in improvement of diabetic nephropathy and in decrease in the amount of proteinuria and cytokine levels.
- Detailed Description
Diabetic nephropathy is leading cause of ESRF that many therapy recommended for it. In this study, we investigate effect of turmeric on diabetic nephropathy, thus we selected diabetic nephropathy patients and divided them into 2 groups. One group received turmeric + ACE inhibitor + Angiotensin II receptor blocker (ARB) and the second group received only ACE inhibitor + ARB.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- diabetic nephropathy
- more than 300 mg proteinuria/day
- age more than 18 years old
Exclusion Criteria
- DM type 1
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ACE inhibitor + ATI blocker Angiotensin-converting enzyme (ACE) inhibitor + Angiotensin-II type 1 receptor (ATI) blocker diabetic nephropathy more than 300 mg/day proteinuria Turmeric Turmeric extract diabetic nephropathy patient more than 300 mg/proteinuria ACE inhibitor + ATI blocker Turmeric extract diabetic nephropathy more than 300 mg/day proteinuria
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Clinic
🇮🇷Shiraz, Fars, Iran, Islamic Republic of